| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |